Deleted No
Hibernated No
Last Checked Nov. 12, 2021

Created

Fri Apr 09 12:00:18 +0000 2021

Likes

5

Retweets

2

Source

Salesforce - Social Studio

View Raw Data

JSON Data

View on Twitter

Likely Available
Profile Image

Teva Pharmaceuticals @TevaUSA

Biosimilar medicines are potentially less expensive than original biologics, whilst having the same effectiveness. Teva’s Cory Wohlbach explains what #biosimilars are and how he is working with government regulators to share his expertise https://t.co/ifooyDwNMy #MeetOurExpert https://t.co/OaxtufTxzZ — PolitiTweet.org

Posted April 9, 2021